Opthea Limited logo
Opthea Limited OPT

Annual report 2022
added 09-29-2022

report update icon

Opthea Limited Shares 2011-2026 | OPT

Annual Shares Opthea Limited

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
352 M 320 M 261 M - 25.2 M 20.2 M 18.8 M 13.6 M 6.22 M 6.21 M 5.95 M 5.91 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
352 M 5.91 M 94.1 M

Shares of other stocks in the Biotechnology industry

Issuer Shares Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
33.4 M - 2.43 % $ 254 M germanyGermany
AgeX Therapeutics AgeX Therapeutics
AGE
10.2 M - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
220 M - - $ 866 M chinaChina
Midatech Pharma plc Midatech Pharma plc
MTP
80.5 M - -18.52 % $ 27.3 M britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
219 M - - $ 40.3 B usaUSA
Biophytis SA Biophytis SA
BPTS
118 M - -13.47 % $ 169 M franceFrance
Genfit SA Genfit SA
GNFT
44.7 B - 2.54 % $ 160 B franceFrance
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
4.58 M - -1.52 % $ 24.7 M usaUSA
Athira Pharma Athira Pharma
ATHA
4.28 M - - $ 269 M usaUSA
BioNTech SE BioNTech SE
BNTX
244 M $ 95.05 -0.47 % $ 27.2 B germanyGermany
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
75 M - - - russiaRussia
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
21.6 M - - $ 231 M usaUSA
INmune Bio INmune Bio
INMB
24.8 M $ 1.55 0.32 % $ 38.4 M usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
166 M $ 22.69 1.5 % $ 3.76 B usaUSA
Advaxis Advaxis
ADXS
6.02 M - -9.65 % $ 45.9 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
1.65 M $ 3.52 -7.12 % $ 5.79 M israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
115 M - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
78.2 M - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
186 M - - $ 867 M germanyGermany
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
45 M - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
14.3 M - 1.93 % $ 17.4 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
67.1 M - - $ 3.67 B usaUSA
Aptose Biosciences Aptose Biosciences
APTO
2.45 M - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
67.7 M - -39.0 % $ 4.57 M usaUSA
Akouos Akouos
AKUS
34.4 M - 0.23 % $ 488 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
19.2 M - -0.23 % $ 916 M usaUSA
Allakos Allakos
ALLK
86.8 M - - $ 28.6 M usaUSA
AlloVir AlloVir
ALVR
15.3 M - 4.14 % $ 49.1 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
127 M $ 23.85 1.81 % $ 3.03 B usaUSA
Nanobiotix S.A. Nanobiotix S.A.
NBTX
34.7 B $ 41.0 17.92 % $ 286 B franceFrance
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
68 M - 3.16 % $ 1.9 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
810 K - -11.43 % $ 502 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
38.8 M - - $ 10.1 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
33.4 M - - $ 2.17 B usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
25.4 M - 10.36 % $ 9.8 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
84.2 M - - $ 8.42 M usaUSA
Aravive Aravive
ARAV
36.4 M - -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
18.8 M - 17.91 % $ 11.1 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
89.9 M $ 54.72 4.47 % $ 4.92 B schweizSchweiz
Avenue Therapeutics Avenue Therapeutics
ATXI
3.13 M - -52.27 % $ 4.45 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
266 M $ 1.72 4.88 % $ 458 M britainBritain
Esperion Therapeutics Esperion Therapeutics
ESPR
208 M $ 3.13 0.55 % $ 651 M usaUSA
AVROBIO AVROBIO
AVRO
44.3 M - 1083.1 % $ 745 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
15.4 M - - $ 7.46 M israelIsrael
Завод ДИОД Завод ДИОД
DIOD
91.5 M - - - russiaRussia
Фармсинтез Фармсинтез
LIFE
301 M - - - russiaRussia
AstraZeneca PLC AstraZeneca PLC
AZN
1.42 B - - $ 96.9 B britainBritain
Exelixis Exelixis
EXEL
272 M $ 47.57 7.09 % $ 12.9 B usaUSA
Atreca Atreca
BCEL
38.6 M - -11.76 % $ 5.79 M usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
9.27 M - -2.5 % $ 5.88 M usaUSA